Medical Beauty · Japan

Japanese Patient Acquisition, Start with a Diagnostic

Before spending on Japanese marketing, validate demand and operational readiness. RIVACTA's Market Diagnostic helps you build a Japan entry strategy without wasting ad budget.

The real challenge

Why Japanese patient acquisition is hard

You've tried Japanese agencies and ads before, but patient acquisition didn't follow — budget was spent without measurable results.

You operate a LINE OA or Japanese landing page, but there's no systematic acquisition funnel or conversion measurement in place.

You're exposed to regulatory risk (Pharmaceutical Affairs Law, Medical Care Act) without understanding Japanese medical advertising compliance.

RIVACTA's approach

Don't execute without diagnosis

RIVACTA's Market Diagnostic evaluates demand, channel readiness, localization depth, and regulatory posture before recommending any paid media or marketing execution.

  • Data-driven analysis of Japan medical beauty search demand and competitive intensity
  • Channel-by-channel patient acquisition potential (LINE, Yahoo!, Google)
  • Japanese consultation flow, consent process, and privacy law readiness assessment
  • Medical device and advertising compliance roadmap (Pharmaceutical Affairs Law, Medical Care Act)
Sample diagnostic: Medical BeautyMedical Beauty · Japan
Patient Demand
Consistent 'Korean plastic surgery' search growth in JP
High
JP Channel
LINE OA active, no JP website
Medium
Consultation Flow
Interpreter-dependent, consent flow gaps
Low
Ad Compliance
Pre-review requirements not addressed
Medium

Methodology credibility

30+Cross-border campaigns diagnosed
5+Japan–Korea market-entry frameworks
12+Categories evaluated
¥1B+Media spend analyzed

Start with a 30-minute Fit Call

No cost, no commitment. Share your situation and we'll tell you honestly whether RIVACTA is the right partner.

common.noCost